NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients-Reference-Cited by-同舟云学术

NS-018, a selective JAK2 inhibitor, preferentially inhibits CFU-GM colony formation by bone marrow mononuclear cells from high-risk myelodysplastic syndrome patients

Published:2014-05 Issue:5 Volume:38 Page:619-624
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kuroda Junya,Kodama Ayumi,Chinen Yoshiaki,Shimura Yuji,Mizutani Shinsuke,Nagoshi Hisao,Kobayashi Tsutomu,Matsumoto Yosuke,Nakaya Yohei,Tamura Ayako,Kobayashi Yutaka,Naito Haruna,Taniwaki Masafumi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Molecular genetics in myelodysplastic syndromes;Haferlach;Leuk Res,2012

2. Cytogenetic, and molecular abnormalities in myelodysplastic syndrome;Nagoshi;Curr Mol Med,2011

3. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management;Garcia-Manero;Am J Hematol,2011

4. Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

5. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS;Park;Eur J Haematol,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into Janus kinases specificity: From molecular architecture to cancer therapeutics;MedComm – Oncology;2024-03

2. Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders;European Journal of Medicinal Chemistry;2020-04

3. Mutation-Driven Therapy in MDS;Current Hematologic Malignancy Reports;2019-11-23

4. Ag-Catalyzed selective fluorination of 6-substituted 2-amionpyrazines;Journal of Fluorine Chemistry;2019-02

5. Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes;Current Pharmaceutical Design;2016-10-03